Related Experiment Video
Updated: May 26, 2026

Assessing Urinary Tract Junction Obstruction Defects by Methylene Blue Dye Injection
Published on: October 12, 2017
Current understanding of usher syndrome type II
Jun Yang1, Le Wang, Hongman Song
1Department of Ophthalmology and Visual Sciences, Moran Eye Center, University of Utah, Salt Lake City, Utah 84132.
Usher syndrome type II (USH2) is a genetic cause of deafness-blindness. Research identifies USH2 protein complexes in sensory cells, suggesting new therapeutic targets for this condition.
Area of Science:
- Genetics
- Ophthalmology
- Audiology
Background:
- Usher syndrome is the leading genetic cause of combined hearing and vision loss.
- Usher syndrome type II (USH2) is the most common form, linked to mutations in three specific genes.
- The proteins encoded by these USH2 genes form a complex crucial for sensory cell function.
Purpose of the Study:
- To investigate the USH2 protein complex's in vivo interactions and potential new components.
- To explore the biological functions of the USH2 complex in photoreceptors and hair cells.
- To identify candidate genes for USH2 and evaluate therapeutic strategies.
Main Methods:
- Analysis of protein interactions in vitro and in vivo.
- Localization studies in photoreceptors and hair cells.
- Examination of phenotypes in USH2 mutant mouse models.
Main Results:
- The USH2 protein complex is localized to the periciliary membrane complex in photoreceptors and stereocilia in hair cells.
- Numerous proteins interact with USH2 proteins in vitro, indicating potential additional complex members.
- USh2 mutant mice exhibit relevant phenotypes, aiding functional predictions.
Conclusions:
- The USH2 protein complex plays a vital role in sensory cell structure and function.
- Further research is needed to confirm in vivo interactions and the full composition of the USH2 complex.
- Understanding the USH2 complex provides a basis for developing targeted therapies for Usher syndrome type II.
Related Concept Videos
Cushing Syndrome II: Pathophysiology
Urinary Tract Infection II: Pathophysiology
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Type I Diabetes II: Pathophysiology
Type II Diabetes II: Pathophysiology
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
